Cooper Companies (The)

COO US Health Care Health Care Supplies
S&P 500
$53.91
-0.48%
Delayed · cached 15 min

Fair value analysis

COO
Cooper Companies (The)
Health CareHealth Care Supplies
$53.91
Close used for this calculation
$38.97Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
39/100
Profitability10/25
Returns4/25
Balance Sheet19/25
Efficiency6/25
Growth3/25
Average
Quality radar
39Prof.10/25Ret.4/25Eff.6/25B.Sht19/25Growth3/25

Consensus fair value

$38.97
Above FV
▼ -27.7% against the close used
Model range $9.33 – $42.10
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear$9.33Fair value$38.97Bull$42.10
FairClose
52-week traded range
52W low $53.9152W high $84.32

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Cooper Companies (The) closed at $53.91, 38.3% above the consensus fair value of $38.97 drawn from 8 valuation models.

Financial DNA score 39/100 — Average. P/E of 28.8x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
$40.55
-24.8%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
$42.10
-21.9%
√(22.5 × EPS × BVPS)
EPS=1.87, BVPS=42.12 · outside Graham range (P/E 28.8, P/B 1.3) — asset-light, treat as a rough floor
P/E Fair Value
$37.40
-30.6%
EPS × 20x (sector P/E)
EPS=1.87, Sector P/E=20x
Peter Lynch (PEG)
$17.50
-67.5%
EPS × Growth% (PEG = 1 is fair)
EPS=1.87, g=9.4%
EV/EBITDA
$40.95
-24.0%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=1.06B
Book Value (P/B)
$9.33
-82.7%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=42.12, ROE=4.6%, g=3%, r=10%
Reverse DCF
$53.91
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 12.1% | Historical: -9.4%
Margin of Safety
$30.01
-44.3%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=40.02, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.